Deciphering the molecular heterogeneity of HER2-positive breast cancer: the critical interplay of hormone receptor status and transcriptomic landscapes
Ilker Sengul, Demet Sengul, Cagri Akalin · 2026
Read Deciphering the molecular heterogeneity of HER2-positive breast cancer: the critical interplay of hormone receptor status and transcriptomic landscapes by Ilker Sengul, Demet Sengul, Cagri Akalin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13534373.txt.
Description
Ilker Sengul, Demet Sengul, and Cagri Akalin discuss in 2026 why HER2-positive breast cancer splits into two distinct groups by hormone receptor status. Cancers with both marks tend to fare better, while those without hormone marks grow larger and present at later stages. Large database work backs this split with gene activity data.
The double-positive group showed richer drug-processing pathways, which may explain better response to hormone therapy. Immune cell mixes in tumours also differed by group, while key gene mutations stayed similar. Readers are urged to treat the two groups as separate diseases in trials.
Catalog record
| CREATOR | Ilker Sengul, Demet Sengul, Cagri Akalin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6230 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |